These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 23692332)

  • 21. Sentinel lymph node biopsy in penile cancer: evolution and insights.
    Izawa J; Kedar D; Wong F; Pettaway CA
    Can J Urol; 2005 Feb; 12 Suppl 1():24-9. PubMed ID: 15780161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sentinel lymph node in carcinoma of the anal canal: a review.
    Damin DC; Rosito MA; Schwartsmann G
    Eur J Surg Oncol; 2006 Apr; 32(3):247-52. PubMed ID: 16289647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of dynamic sentinel lymph node biopsy in patients with squamous cell carcinoma of the penis and palpable inguinal nodes.
    Heyns CF; Theron PD
    BJU Int; 2008 Aug; 102(3):305-9. PubMed ID: 18410439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma.
    Gröbe A; Eichhorn W; Fraederich M; Kluwe L; Vashist Y; Wikner J; Smeets R; Simon R; Sauter G; Heiland M; Blessmann M
    J Oral Pathol Med; 2014 Mar; 43(3):205-10. PubMed ID: 24020871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of effective chemoradiotherapy using S-1 and CDDP for left inguinal lymph node metastasis of anal canal carcinoma].
    Kuga Y; Tanaka T; Arita M; Usui Y; Okanobu H; Numata Y; Miwata T; Yoshimi S; Murakami E; Moriya T; Ohya T; Nishida T
    Gan To Kagaku Ryoho; 2009 Nov; 36(11):1923-5. PubMed ID: 19920402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of inguinal lymph node recurrence after chemo-radiation for anal canal squamous carcinoma].
    Murata K; Okamura S; Wada Y; Makino S; Kato R; Nishigaki T; Owada Y; Murakami M; Okada K; Ebisui C; Yokouchi H; Kinuta M
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2275-7. PubMed ID: 23268048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. YKL-40 expression in anal carcinoma predicts shorter overall and disease-free survival.
    Castellano I; Mistrangelo M; Crudo V; Chiusa L; Lupo R; Ricardi U; Morino M; Mussa A; Cassoni P
    Histopathology; 2009 Aug; 55(2):238-40. PubMed ID: 19694834
    [No Abstract]   [Full Text] [Related]  

  • 28. The sentinel node in anal carcinoma.
    Mistrangelo M; Mobiglia A; Mussa B; Bellò M; Pelosi E; Goss M; Bosso MC; Moro F; Sandrucci S
    Tumori; 2002; 88(3):S51-2. PubMed ID: 12369553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The analysis of the outcomes and factors related to iliac-obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases.
    Zdzienicki M; Rutkowski P; Nowecki ZI; van Akkooi AC; Michej W; Dziewirski W; Świtaj T; Pieńkowski A; Sałamacha M; Bylina E; Eggermont AM
    Eur J Surg Oncol; 2013 Mar; 39(3):304-10. PubMed ID: 23298828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sentinel node mapping in anal canal cancer: systematic review and meta-analysis.
    Tehranian S; Treglia G; Krag DN; Dabbagh Kakhki VR; Zakavi SR; Sadeghi R; Keshtgar M
    J Gastrointestin Liver Dis; 2013 Sep; 22(3):321-8. PubMed ID: 24078990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced radiation dose for elective nodal irradiation in node-negative anal cancer: back to the roots?
    Henkenberens C; Meinecke D; Michael S; Bremer M; Christiansen H
    Strahlenther Onkol; 2015 Nov; 191(11):845-54. PubMed ID: 26307627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
    Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L
    Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Groin surgery and risk of recurrence in lymph node positive patients with vulvar squamous cell carcinoma.
    Nooij LS; Ongkiehong PJ; van Zwet EW; Bosse T; Creutzberg CL; Gaarenstroom KN; van Poelgeest MI
    Gynecol Oncol; 2015 Dec; 139(3):458-64. PubMed ID: 26432039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sentinel node biopsy for squamous-cell carcinoma of the anus and anal margin.
    Perera D; Pathma-Nathan N; Rabbitt P; Hewett P; Rieger N
    Dis Colon Rectum; 2003 Aug; 46(8):1027-9; discussion 1030-1. PubMed ID: 12907894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The technique of sentinel lymph nodes in patients with anus neoplasm].
    Mistrangelo M; Mobiglia A; Bellò M; Beltramo G; Cassoni P; Mussa A
    Suppl Tumori; 2005; 4(3):S32-3. PubMed ID: 16437886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidermal growth factor receptor expression as prognostic marker in patients with anal carcinoma treated with concurrent chemoradiation therapy.
    Fraunholz I; Rödel F; Kohler D; Diallo-Georgiopoulou M; Distel L; Falk S; Rödel C
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):901-7. PubMed ID: 23755922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nodal stage migration and prognosis in anal cancer: a systematic review, meta-regression, and simulation study.
    Sekhar H; Zwahlen M; Trelle S; Malcomson L; Kochhar R; Saunders MP; Sperrin M; van Herk M; Sebag-Montefiore D; Egger M; Renehan AG
    Lancet Oncol; 2017 Oct; 18(10):1348-1359. PubMed ID: 28802802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of preoperative ultrasound evaluation of inguinal lymph nodes in patients with vulvar malignancy.
    de Gregorio N; Ebner F; Schwentner L; Friedl TW; Deniz M; Látó K; Kreienberg R; Janni W; Varga D
    Gynecol Oncol; 2013 Oct; 131(1):113-7. PubMed ID: 23932893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival impact and predictive factors of axillary recurrence after sentinel biopsy.
    Houvenaeghel G; Classe JM; Garbay JR; Giard S; Cohen M; Faure C; Charytansky H; Rouzier R; Daraï E; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Fraisse J; Dravet F; Chauvet MP; Goncalves A; Lambaudie E
    Eur J Cancer; 2016 May; 58():73-82. PubMed ID: 26971077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial.
    Trovik J; Wik E; Werner HM; Krakstad C; Helland H; Vandenput I; Njolstad TS; Stefansson IM; Marcickiewicz J; Tingulstad S; Staff AC; ; Amant F; Akslen LA; Salvesen HB
    Eur J Cancer; 2013 Nov; 49(16):3431-41. PubMed ID: 23932335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.